📊 According to Lupus Europe’s Swiss Knife Survey, 84.9% reported fatigue.
That’s why we are at “Tired is not just a state of mind”, chaired by @ChristinaDusing & @ElefanteEl79882: fatigue impacts life with RMDs and must be acknowledged and addressed.
#EULAR2026
New Research: Different phenotypes of severe flares in patients with systemic lupus erythematosus: results of a clustering analysis in a monocentric cohort https://t.co/A7WAbU0tTH #FrontiersIn#Immunology
🚨🚨🚨 AHHH we have just been granted a 🔓 FREE 50-DAY ACCESS LINK to the expert #consensus on the therapeutic management of RARE systemic #lupus erythematosus manifestations
Can you please re-tweet the link so that a MAXIMUM have access for free 🔄 LINK: https://t.co/wNrq1i2Cms
🚨 New trial results! 💊
💉 IFX & ADA show efficacy in treating severe mucocutaneous Behçet’s syndrome🌟💥
Both anti-TNFi´s improved symptoms & QoL significantly over 6 months 🔥
✅ 94% ADA response
✅ 64% IFX response
✅ Safe & effective!
🔗 https://t.co/CqXccPGLP0
‼️This study by @ElefanteEl79882 et al. shows that addressing the communication gap can improve treatment outcomes & patient satisfaction.
😕What are the main reasons for not incorporating the patient's perspective in managing #SLE? Prof @Lupusreference at #LupusAcademy2024
#AugustIssue | Update on the pathophysiology and treatment of primary Sjögren syndrome
Learn about emerging therapies for #Sjögren syndrome, including strategies such as inhibition of IgG recycling and CAR T cell therapy, in this #Review
https://t.co/3Xr2Ayc6b4
🎉🎊 New!
2023 EULAR recommendations for management of fatigue is just published!
Highlights 🔍🔎
➡️ Regular assessment of fatigue severity 📈 📉
➡️ Offering fatigue management, including non-pharmacological 🏃♀️ and pharmacological 💊 interventions
Link:
https://t.co/6PSdOFiCLz
Post-Global Rheumatology Networking Reception Dinner 😃🌮 🌯 - great to exchange experiences with colleagues from various countries over nice foods #ACR23@ACRheum@Eular@Aplar
We are delighted to welcome the ACR-EULAR-APLAR Research Exchange scholars to the UC San Diego Altman Clinical and Translational Research Institute. A big thank you to all participants and the program host Dr. Gary Firestein! 🌏 @eular_org@APLAR_org@ucsdactri#ACR23